DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
EXICORILANT
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
EXICORILANT
×
Maximum Phase:
1
First Approval:
None
UNII:
GTB859B7K8
Molecule Type:
Small molecule
Molecular Formula:
C26H23F4N7O3S
Molecular Weight:
589.58
AlogP:
3.23
PSA:
115.87
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MSC-2363318A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSC-2363318A
×
Maximum Phase:
1
First Approval:
None
UNII:
0DXG50I4WD
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DPOC-4088
1
Small molecule
Investigational
Unknown
Unknown
Venous Thrombosis
Unknown
DPOC-4088
×
Maximum Phase:
1
First Approval:
None
UNII:
S6MPG81Y84
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClF3N6O2
Molecular Weight:
452.82
AlogP:
2.35
PSA:
101.8
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VK-0214
1
Small molecule
Investigational
Unknown
Unknown
Adrenoleukodystrophy
Unknown
VK-0214
×
Maximum Phase:
1
First Approval:
None
UNII:
6FGG71NJ3Y
Molecule Type:
Small molecule
Molecular Formula:
C23H25O5P
Molecular Weight:
412.42
AlogP:
4.7
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
7.0
Source:
L-778123
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
L-778123
×
Maximum Phase:
1
First Approval:
None
UNII:
2A2059P49U
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN5O
Molecular Weight:
405.89
AlogP:
3.31
PSA:
65.16
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CC-11006
1
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes
Unknown
CC-11006
×
Maximum Phase:
1
First Approval:
None
UNII:
6DC9826KIM
Molecule Type:
Small molecule
Molecular Formula:
C18H17N3O5
Molecular Weight:
355.35
AlogP:
0.11
PSA:
112.65
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CE-245677
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase TIE-2 inhibitor
CE-245677
×
Maximum Phase:
1
First Approval:
None
UNII:
GMH17J9LHL
Molecule Type:
Small molecule
Molecular Formula:
C24H22Cl2N6O3
Molecular Weight:
513.39
AlogP:
5.78
PSA:
124.16
HBD:
3.0
HBA:
#RotB:
6.0
Source:
5-METHYL-2'-FLUOROARAURACIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-METHYL-2'-FLUOROARAURACIL
×
Maximum Phase:
1
First Approval:
None
UNII:
37F7D05ANB
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN2O5
Molecular Weight:
260.22
AlogP:
-1.57
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ABT-102
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
ABT-102
×
Maximum Phase:
1
First Approval:
None
UNII:
J0YBN3USJN
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.67
PSA:
69.81
HBD:
3.0
HBA:
#RotB:
2.0
Source:
BFH772
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BFH772
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
5-AMINOVALERIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-AMINOVALERIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.2
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SRX251
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vasopressin V1a receptor antagonist
SRX251
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHS-828
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CHS-828
×
Maximum Phase:
1
First Approval:
None
UNII:
8LAP87DNSZ
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN5O
Molecular Weight:
371.87
AlogP:
4.21
PSA:
82.33
HBD:
2.0
HBA:
#RotB:
9.0
Source:
OSI-027
1
Small molecule
Investigational
Unknown
Unknown
Lymphedema; Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
OSI-027
×
Maximum Phase:
1
First Approval:
None
UNII:
25MKH1SZ0M
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O3
Molecular Weight:
406.45
AlogP:
3.22
PSA:
131.42
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CG-200745
1
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms
Unknown
CG-200745
×
Maximum Phase:
1
First Approval:
None
UNII:
4I8MLM7L2H
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4
Molecular Weight:
427.55
AlogP:
3.28
PSA:
90.9
HBD:
3.0
HBA:
#RotB:
13.0
Source:
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOAMYL 2-CYANOACRYLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ISOAMYL 2-CYANOACRYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-733
1
Small molecule
Investigational
Unknown
Unknown
Adenomatous Polyposis Coli; Melanoma; Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
TAK-733
×
Maximum Phase:
1
First Approval:
None
UNII:
5J61HSP0QJ
Molecule Type:
Small molecule
Molecular Formula:
C17H15F2IN4O4
Molecular Weight:
504.23
AlogP:
1.07
PSA:
109.38
HBD:
3.0
HBA:
#RotB:
5.0
Source:
APC-100
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor antagonist
APC-100
×
Maximum Phase:
1
First Approval:
None
UNII:
7G73627R36
Molecule Type:
Small molecule
Molecular Formula:
C14H20O2
Molecular Weight:
220.31
AlogP:
3.42
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
0.0
Source:
PAC-1
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Glioblastoma; Uveal Melanoma
Unknown
PAC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
9LIS8N0B2C
Molecule Type:
Small molecule
Molecular Formula:
C23H28N4O2
Molecular Weight:
392.5
AlogP:
2.39
PSA:
68.17
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VTP-27999
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VTP-27999
×
Maximum Phase:
1
First Approval:
None
UNII:
254XY8NV84
Molecule Type:
Small molecule
Molecular Formula:
C26H41ClN4O5
Molecular Weight:
525.09
AlogP:
3.58
PSA:
101.16
HBD:
3.0
HBA:
#RotB:
11.0
Source:
PF-04937319
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-04937319
×
Maximum Phase:
1
First Approval:
None
UNII:
7E99B9ZM19
Molecule Type:
Small molecule
Molecular Formula:
C22H20N6O4
Molecular Weight:
432.44
AlogP:
3.38
PSA:
123.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TELINAVIR
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 protease inhibitor
TELINAVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
IZF55EH3CG
Molecule Type:
Small molecule
Molecular Formula:
C33H44N6O5
Molecular Weight:
604.75
AlogP:
2.76
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
13.0
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
BTZ-043
1
Small molecule
Investigational
Unknown
Unknown
Tuberculosis; Tuberculosis, Pulmonary
Unknown
BTZ-043
×
Maximum Phase:
1
First Approval:
None
UNII:
G55ZH52P57
Molecule Type:
Small molecule
Molecular Formula:
C17H16F3N3O5S
Molecular Weight:
431.39
AlogP:
3.32
PSA:
94.8
HBD:
0.0
HBA:
#RotB:
2.0
Source:
SAD448
1
Small molecule
Investigational
Unknown
Unknown
Ocular Hypertension
Cannabinoid CB1 receptor agonist
SAD448
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O8S
Molecular Weight:
532.58
AlogP:
1.31
PSA:
165.92
HBD:
3.0
HBA:
#RotB:
9.0
Source:
TELRATOLIMOD
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell, Cutaneous; Zika Virus Infection
Toll-like receptor 7 agonist
TELRATOLIMOD
×
Maximum Phase:
1
First Approval:
None
UNII:
16598XQ2BT
Molecule Type:
Small molecule
Molecular Formula:
C36H59N5O2
Molecular Weight:
593.9
AlogP:
9.1
PSA:
95.06
HBD:
2.0
HBA:
#RotB:
25.0
Source:
VIPIVOTIDE TETRAXETAN
1
Small molecule
Investigational
Unknown
Unknown
Diagnostic Imaging; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
VIPIVOTIDE TETRAXETAN
×
Maximum Phase:
1
First Approval:
None
UNII:
4YM1W0EGQ5
Molecule Type:
Small molecule
Molecular Formula:
C49H71N9O16
Molecular Weight:
1042.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
SU-9516
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cyclin-dependent kinase 2 inhibitor
SU-9516
×
Maximum Phase:
1
First Approval:
None
UNII:
FD2SWT2SDI
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O2
Molecular Weight:
241.25
AlogP:
1.91
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
2.0
Source:
CROLIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Thyroid Neoplasms
Tubulin inhibitor
CROLIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9ENT43KY91
Molecule Type:
Small molecule
Molecular Formula:
C18H17BrN4O3
Molecular Weight:
417.26
AlogP:
2.85
PSA:
129.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FRUCTOSE
1
Small molecule
Investigational
Unknown
Unknown
Hypoglycemia; Melanoma; Non-alcoholic Fatty Liver Disease; Obesity
Unknown
FRUCTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
6YSS42VSEV
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
ME-344
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Neoplasms
Mitochondrial complex I (NADH dehydrogenase) inhibitor
ME-344
×
Maximum Phase:
1
First Approval:
None
UNII:
843G0TDV51
Molecule Type:
Small molecule
Molecular Formula:
C22H20O4
Molecular Weight:
348.4
AlogP:
4.42
PSA:
69.92
HBD:
3.0
HBA:
#RotB:
2.0
Source:
1
2
…
60
61
62
63
64
65
66
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA